Latest filing published 25 Jun 2024 for Gland Pharma Limited, €10k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Prakash Baliga: trading record in brief
Prakash Baliga is a declared insider of Gland Pharma Limited (chief executive), with filings sourced from SEBI (PIT + SAST). In total, 15 filings cover trades dated from 7 June 2021 to 24 June 2024.
The open-market record consists of 13 sales worth €1.3M, with no purchase. Other entries cover 2 share grants. So far in 2024, the count stands at no purchases and 3 sales.
On 25 June 2024 came the latest disclosure, an open-market sale for €10k in Gland Pharma Limited. The median gap between a trade and its publication by SEBI (PIT + SAST) is 1 day. Until a filing is published, the market cannot know about the trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEBI (PIT + SAST) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Prakash Baliga
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 500 shares@ ₹1,817.0560.8% of flowEquity SharesSEBI:605952386b5df2383e2f901adac2a3a3386e1487
- 13,000 shares@ ₹1,825.337819.8% of flowEquity SharesSEBI:3b73e8629777115c75d3c67c9e4c64c26cb49676
- 13,500 shares@ ₹542.006.0% of flowEquity SharesSEBI:a20dc8534285d6623e46638a10a13b5765a0c8dcCanonical exit: 5 Sept 2024 (T+90)
- 1,525 shares@ ₹1,844.66822.3% of flowEquity SharesSEBI:db553d3574898d19d3abfe99ff269ff6dada17fc
- 1,010 shares@ ₹1,315.99011.1% of flowEquity SharesSEBI:885558dd7b2a0bbcf703c83a8268ef7954998f37
- 1,726 shares@ ₹1,364.34012.0% of flowEquity SharesSEBI:f15d8700f5e73120080f2202ac07e63ec063799c
- 500 shares@ ₹1,365.540.6% of flowEquity SharesSEBI:0eead13760978724313b02eb4b237cfe93d38e9a
- 3,000 shares@ ₹2,645.35577.2% of flowEquity SharesSEBI:fa809043be788553e53605d0054c8cb8f15ba927
- 1,000 shares@ ₹2,649.502.4% of flowEquity SharesSEBI:d6cafb175c7d5f85ac15eb42b738a29af1d948a3
- 4,000 shares@ ₹2,558.37439.3% of flowEquity SharesSEBI:d2f952b1b6a126bf222c1359dcf6c614d93d5d7e
- 2,301 shares@ ₹2,613.99915.5% of flowEquity SharesSEBI:75919a3d7085c3786f57d460be6916be018a35ad
- 1,424 shares@ ₹2,662.5733.4% of flowEquity SharesSEBI:28ecfad3bad1632f89356fadc6b075ed3434a68b
- 16,500 shares@ ₹542.00100.0% of flowEquity SharesSEBI:ef738836e21a3caf9ffb4992bf65209d846772f3Canonical exit: 5 Jan 2022 (T+90)
- 10,000 shares@ ₹3,138.01430.0081% mcap26.4% of flowEquity SharesSEBI:58550c371bad5df32496af45f6f1b7881e4b9533
- 5,000 shares@ ₹3,140.3680.0040% mcap13.2% of flowEquity SharesSEBI:cdfb92f6988348a08bf636792f43248d2efe2f4b
15 of 15 declarations